SCHEMBL5360083

SCHEMBL5360083

O=C(O)c1ccc(C(F)(C(F)(F)F)C(F)(F)F)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
KIF11 P52732 1/20 0.42
TTR P02766 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 2/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL418896 0.87 LMNA (0.49) LMNAMAPK1HTTRAB9AKIF11
SCHEMBL29620952 0.85 KIF11 (0.57) LMNAMAPK1HTTRAB9AKIF11
SCHEMBL850429 0.85 KIF11 (0.57) LMNAMAPK1HTTRAB9AKIF11
SCHEMBL5357660 0.84 KIF11 (0.57) RAB9AKIF11MAPTL3MBTL1CES2
SCHEMBL5359738 0.84 PARP1 (0.43) KIF11HSD17B10L3MBTL1CES2CES1
Hydrochloric Acid SCHEMBL31439018 0.83 KIF11 (0.56) LMNAMAPK1HTTRAB9AKIF11
SCHEMBL16104820 0.81 LMNA (0.51) LMNAMAPK1HTTRAB9AKIF11
SCHEMBL5354014 0.80 TSHR (0.45) LMNAMAPK1HTTRAB9ASMN1; SMN2
SCHEMBL5355256 0.80 NOTUM (0.56) LMNAHTTKIF11SMN1; SMN2KDM4E
SCHEMBL11977452 0.79 LMNA (0.53) LMNAMAPK1HTTRAB9AKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7169955-B2 Perfluoroisopropylbenzene derivative NIHON NOHYAKU CO., LTD. (JP) 2007-01-30 US disclosed
US-20050113567-A1 Perfluoroisopropylbenzene derivative NIHON NOHYAKU CO., LTD. (JP) 2005-05-26 US disclosed
US-20030187233-A1 PERFLUOROISOPROPYBENZENE DERIVATIVE NIHON NOHYAKU CO., LTD. (JP) 2003-10-02 US disclosed
EP-1253128-A1 PERFLUOROISOPROPYLBENZENE DERIVATIVES Nihon Nohyaku Co., Ltd. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187233-A1 PERFLUOROISOPROPYBENZENE DERIVATIVE AFF1, CBR1, RER1 LMNA 2317/4885MAPK1 1518/4885HTT 615/4885
US-20050113567-A1 Perfluoroisopropylbenzene derivative FFAR3, CBR3, HCAR3 LMNA 2634/4885MAPK1 3271/4885HTT 668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.